The FDA has approved lirafugratinib (Lyrfigtu), a new targeted therapy for patients with advanced cholangiocarcinoma, also known as bile duct cancer, that carries specific FGFR2 genetic mutations. Thi

A recent Phase 3 clinical trial highlighted a new bispecific antibody, etentamig, as a promising treatment for patients with triple-class–exposed multiple myeloma. The drug significantly improved the

Scientists have identified a new type of stem cell responsible for forming tendons and ligaments throughout the body. In patients with lumbar spinal stenosis, these cells become overactive, causing li

Longeveron Inc. announced new data analysis from its Phase 2a clinical trial (CLEAR MIND study) for laromestrocel, a cell therapy for Alzheimer's disease. The analysis indicates that treatment with la

A new blood test, ScolimiR-3D, has received FDA Breakthrough Device designation for its ability to predict the worsening of adolescent idiopathic scoliosis (AIS). This innovative diagnostic tool measu

Researchers at MIT have developed a groundbreaking new method, utilizing an AI algorithm, to formulate RNA vaccines that remain stable at significantly higher temperatures. This innovation addresses a

Scientists have discovered a way to boost the heart's natural repair mechanisms after a heart attack by changing how heart cells produce energy. This bioengineering advance, demonstrated in mice, trig

Filament Health, a subsidiary of Rhelion Life Sciences, has sent its standardized psilocybin drug candidate, PEX010, to the University of Calgary. This shipment is for a Phase 2 clinical trial aimed a

MediciNova, Inc. has reported encouraging topline data from its Phase 2 clinical trial (MN-001-NATG-202) of MN-001 (tipelukast). The study investigated the drug's efficacy in treating hypertriglycerid

Adicet Bio, Inc. has announced positive safety and efficacy results from its Phase 1 study of prula-cel, an investigational allogeneic CAR-T cell therapy, for patients with systemic lupus erythematosu

New research presented at the European Association for the Study of Diabetes (EASD) in Milan suggests that changes in gut bacteria could predict future type 2 diabetes risk even before blood sugar lev

A groundbreaking Phase 1 clinical trial conducted by Cleveland Clinic has revealed that a single infusion of a CRISPR-Cas9 gene-editing therapy significantly reduced levels of "bad" cholesterol (LDL)

UF Health has successfully performed the first robotic-assisted nipple-sparing mastectomies, a technique that recently received FDA approval in the United States. This innovative approach allows for t

The U.S. Food and Drug Administration (FDA) has approved Veppanu, a new oral medication, for the treatment of specific types of advanced breast cancer. This treatment is intended for adult patients wh

The U.S. Food and Drug Administration (FDA) has accepted Intellia Therapeutics' application for lonvoguran ziclumeran (lonvo-z), an in vivo CRISPR-Cas gene-editing therapy, and granted it priority rev

A new Phase 1/2 clinical trial involving 30 patients demonstrates that genetically modifying donor stem cells with CRISPR to remove the CD33 protein can allow targeted cancer therapies to attack aggre

Google DeepMind and EMBL-EBI have made AI-predicted 3D protein complex structures for over 2,800 viruses openly accessible in the AlphaFold Database. This groundbreaking release aims to enhance unders

Moderna and Merck are preparing to seek regulatory approval for their personalized mRNA cancer vaccine, intismeran, after it successfully met its primary and a secondary endpoint in a Phase 3 trial fo

Researchers at Washington University School of Medicine have discovered dozens of blood proteins that change in patients receiving the Alzheimer's drug lecanemab. This finding could lead to new, less

A recent study published in The Lancet Neurology found that patients with early symptomatic Alzheimer's disease show significantly different biological responses when treated with lecanemab, an anti-a

Researchers at Duke University have discovered that a molecule produced by the human gut bacterium *Clostridium immunis* can help obese mice burn fat more efficiently. This unique sugar molecule, modi

The U.S. Food and Drug Administration (FDA) has approved a new combination treatment consisting of belzutifan (Welireg) and lenvatinib (Lenvima) for adults battling advanced renal cell carcinoma, a ty

A new study has revealed that children prescribed GLP-1 medications, commonly used for weight loss and diabetes, may be at an increased risk of developing nutritional deficiencies. This finding highli

Mount Sinai researchers have discovered a critical mechanism by which the APOE4 gene, a major genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the accumulati

In a groundbreaking medical advancement, the world's first telerobotic neurosurgery for stroke treatment was successfully performed in Panama. A neurosurgeon remotely guided a robotic system to remove

Armata Pharmaceuticals has received FDA Breakthrough Therapy designation for AP-SA02, an intravenous multi-phage therapy designed to combat complicated Staphylococcus aureus bacteremia, including anti

Nigerian surgeons have successfully performed the country's first tele-robotic surgery, with a surgeon located in Lagos remotely operating on a patient suffering from kidney cancer in Abuja, approxima

Genentech's investigational drug, enicepatide (CT-388), a once-weekly dual GLP-1/GIP receptor agonist, has shown promising results in a Phase II clinical trial for adults with type 2 diabetes and over

An experimental CRISPR-Cas9 gene-editing treatment, CTX310, has shown promising early results in a Phase 1 trial. A single infusion of the therapy was reported to safely reduce LDL, or 'bad,' choleste

Scientists have found that stem cell transplants can regenerate stroke-damaged brain tissue in mice, leading to the formation of new neurons and the recovery of lost motor function. This breakthrough

The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first influenza vaccine in the U.S. to utilize mRNA technology, specifically for adults aged 50 and older. This new vaccine aims

Researchers from Mass General Brigham have discovered that children genetically predisposed to type 1 diabetes face a significantly higher risk if their gut microbiome development plateaus prematurely

Researchers at FIU have developed a novel high-throughput screening method to efficiently discover new antibiotics by targeting bacterial DNA gyrase. While testing this innovative approach, they ident

A major 20-country research commission has found that sharing vaccines more equitably, based on population size rather than purchasing power, could save an additional 2.7 million lives in a future flu

A novel triple-action cancer drug, amivantamab, has shown promising results in a Phase 1b/2 clinical trial for patients with HPV-unrelated recurrent/metastatic head and neck squamous cell cancer who h

A new clinical trial challenges the standard practice of prolonged antibiotic use for orthopedic infections. The study found that a short course of systemic antibiotics (7 days or less) was as effecti

Scientists have discovered a powerful new antibiotic, pre-methylenomycin C lactone, hidden within a compound that has been known for 50 years. This new compound demonstrates strong activity against dr

A new study from the University of Sydney found that older adults aged 65 to 75 who adopted specific dietary changes for only four weeks showed signs of reduced biological age. Participants experience

A personalized mRNA cancer vaccine, developed by Moderna and Merck, has demonstrated significant success in late-stage clinical trials for melanoma. When combined with existing immunotherapy, the vacc

Stanford researchers have developed a "virtual biotech company" utilizing 37,000 AI agents to streamline drug discovery. This innovative AI system successfully predicted which drug candidates would li

Otsuka Pharmaceutical has unveiled new Phase 3b clinical trial results for its drug SIMTRIYO (centanafadine), demonstrating consistent improvements in adults suffering from attention-deficit/hyperacti

A new report from Yale School of Public Health and the Edelman Trust Institute reveals surprising insights into patient behavior, finding that education and healthcare access do not necessarily correl